6533b862fe1ef96bd12c77ac

RESEARCH PRODUCT

Letter: proton pump inhibitor use and bone fracture risk-a mechanistic point of view. Authors' reply

Jörn M. SchattenbergChristian Labenz

subject

Liver CirrhosisMaleHepatologymedicine.drug_classbusiness.industryGastroenterologyProton-pump inhibitorProton Pump InhibitorsBone fracturemedicine.diseaseBioinformaticsFractures BonemedicineHumansPharmacology (medical)Point (geometry)businesshttps://doi.org/10.1111/apt.16257